Heron Therapeutics
HRTX
HRTX
186 hedge funds and large institutions have $621M invested in Heron Therapeutics in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 75 increasing their positions, 47 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
9.13% less ownership
Funds ownership: 115.41% → 106.28% (-9.1%)
39% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 36
42% less capital invested
Capital invested by funds: $1.07B → $621M (-$453M)
Holders
186
Holding in Top 10
2
Calls
$7.75M
Puts
$2.57M
Top Buyers
| 1 | +$29.9M | |
| 2 | +$7.22M | |
| 3 | +$6.74M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.91M |
| 5 |
OCM
Orchard Capital Management
Chicago,
Illinois
|
+$3.44M |
Top Sellers
| 1 | -$75.6M | |
| 2 | -$23.2M | |
| 3 | -$16.6M | |
| 4 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
-$12.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.47M |